Use of activated t-cells to enhance anti-tumor activity of bispecific antibodies or bites
US-2024091257-A1 · Mar 21, 2024 · US
This page is not indexed by search engines while we improve data quality.
Borrello Ivan M patents
Borrello Ivan M is listed as an inventor on 21 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Borrello Ivan M |
| Total patents | 21 |
| First publication | Nov 12, 2015 |
| Latest publication | Mar 21, 2024 |
Notable patents
Publications ranked by popularity score, then publication date.
Marrow infiltrating lymphocytes (mils) as a source of t-cells for chimeric antigen receptor (car) thereapy
US-2023210990-A1 · Jul 6, 2023 · US
Marrow infiltrating lymphocytes (mils) as a source of t-cells for chimeric antigen receptor (car) thereapy
US-2023016031-A1 · Jan 19, 2023 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-2023000919-A1 · Jan 5, 2023 · US
Marrow infiltrating lymphocytes (MILs) as a source of T-cells for chimeric antigen receptor (CAR) therapy
US-11478548-B2 · Oct 25, 2022 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-11406666-B2 · Aug 9, 2022 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-2022016172-A1 · Jan 20, 2022 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-11160830-B2 · Nov 2, 2021 · US
Activation of Marrow Infiltrating Lymphocytes in Hypoxic Alternating with Normoxic Conditions
US-2019350982-A1 · Nov 21, 2019 · US
Activation of Marrow Infiltrating Lymphocytes in Hypoxic Alternating with Normoxic Conditions
US-2019298768-A1 · Oct 3, 2019 · US
Recent patents
Latest publications not already listed above.
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-10406178-B2 · Sep 10, 2019 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-10172887-B2 · Jan 8, 2019 · US
Marrow Infiltrating Lymphocytes (MILS) as a Source of T-Cells for Chimeric Antigen Receptor (CAR) Thereapy
US-2018200367-A1 · Jul 19, 2018 · US
Immune checkpoint chimeric antigen receptors therapy
US-2018185434-A1 · Jul 5, 2018 · US
Activation of Marrow Infiltrating Lymphocytes in Hypoxic Alternating with Normoxic Conditions
US-2017266232-A1 · Sep 21, 2017 · US
Activation of Marrow Infiltrating Lymphocytes in Hypoxic Alternating with Normoxic Conditions
US-2017258838-A1 · Sep 14, 2017 · US
Pde inhibitors in immunotherapy
US-2017224691-A1 · Aug 10, 2017 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-9687510-B2 · Jun 27, 2017 · US
Activation of marrow infiltrating lymphocytes in hypoxic alternating with normoxic conditions
US-2016331781-A1 · Nov 17, 2016 · US
PDE5 inhibitor compositions and methods for immunotherapy
US-9468643-B2 · Oct 18, 2016 · US
Use of Post-Transplant Cyclophosphamide Treated Allogeneic Marrow Infiltrating Lymphocytes to Augment Anti-Tumor Immunity
US-2015320798-A1 · Nov 12, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Univ Johns Hopkins | 21 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 20 |
| A61K35/17 | 19 |
| A61K40/11 | 18 |
| C12N5/0636 | 18 |
| A61K40/42 | 14 |